Fenfuro abstract title: Clinical study to determine efficacy of trigonella foenum-graecum extract in patients with type 2 diabetes selected for poster presentation at IDF Diabetes Complications Congress 2018, on 25 to 27 October at the Hyderabad International Convention Centre, Hyderabad, India.
Abstract Submission: “Clinical Evaluation Of Standardized Fenugreek Seed Extract As Furostanolic Saponins (Furocyst) In Polycystic Ovary Syndome Patients.”
Abstract Submission: “Clinical Evaluation Fenugreek Seed Extract In Patients With Type-2 Diabetes: An Add-on Study In 154 Patients”
Abstract Submission: Safety, Efficacy And Toxicological Evaluation Of A Novel, Patented Anti-diabetic Extract Of Trigonella Foenum-graecum Seed Extract (Fenfuro)
Abstract submission: ” Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of trigonella foenum-graecum seed extract (fenfuro).”
Abstract Submission: Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro)
Abstract Submission: “Anti-diabetic efficacy of Fenfuro, a novel, patented Trigonella foenum-graecum seed extract (1019.14)”
Abstract Submission: “Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro)”